Skip to main content
See every side of every news story
Published loading...Updated

EVERSANA Buys Digital Drug-Price Marketplace Firm Waltz Health

The $6 billion merger aims to disrupt drug distribution by integrating AI-driven marketplaces and payer connections to reduce costs and improve patient access, executives said.

Summary by Pharmaphorum
Pharma commercialisation services provider EVERSANA (pharmaphorum's parent company) has acquired Waltz Health, a Chicago digital health company offering AI-driven marketplaces to lower overall drug costs. The terms of the deal were not disclosed.

Bias Distribution

  • 67% of the sources are Center
67% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Bloomberg broke the news in United States on Tuesday, August 26, 2025.
Sources are mostly out of (0)
News
For You
Search
BlindspotLocal